Good safety profile The vaccine’s safety has been demonstrated after more than 4.5 million vaccine doses have been given to nearly 1.5 million children.
Feasibility to deliver in routine immunization programmes The high, equitable vaccine coverage that was achieved during pilot introductions showed high community demand, health worker acceptability, and the capacity of countries to effectively deliver the vaccine.
13423
良好的安全性 在向近150万儿童接种了450多万剂疫苗后,该疫苗的安全性得到了证明。
Importantly, malaria vaccine introduction resulted in no reduction in insecticide-treated bednet (ITN) use, uptake of other childhood vaccines, or care-seeking behaviour for fever.
Equity The vaccine increases equity in access to malaria prevention tools: in pilot introductions, the vaccine reached more than two-thirds of children who are not sleeping under an ITN.
Cost-effective The malaria vaccine is estimated to be cost-effective in areas of moderate to high malaria transmission The RTS,S vaccine was prequalified by WHO in July 2022.
13427
世卫组织对RTS,S疟疾疫苗有何建议,这对疟疾流行国家意味着什么?
What is the WHO recommendation for the RTS,S malaria vaccine and what does this mean for endemic countries?
In October 2021, on the advice of two WHO global advisory bodies, one for immunization and the other for malaria, the Organization made this recommendation.
WHO recommends the RTS,S/AS01 malaria vaccine be used for the prevention of P. falciparum malaria in children living in regions with moderate to high transmission as defined by WHO.
13430
世卫组织关于首个疟疾疫苗的建议载于 《疟疾疫苗:世卫组织立场文件——2022年3月》 。
WHO recommendations for the first malaria vaccine are provided in the Malaria vaccine: WHO position paper – March 2022 .